Hye Jin Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hye Jin Kim has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Keun-Hong Park
Department of Nano-regenerative Medical Engineering, College of Life Science, CHA University, 6F, CHA Biocomplex, Sampyeong-Dong, Bundang-gu, Seongnam-si, 13488, Republic of Korea
6 shared publications Hui Bang Cho
Laboratory of Nano-regenerative Medicine, Department of Biomedical Science, College of Life Science, CHA University, CHA Biocomplex, Sampyeong-Dong, Bundang-gu, Seongnam-si, 13488, Republic of Korea
5 shared publicationsSujeong Lee
Laboratory of Nano-regenerative Medicine, Department of Biomedical Science, College of Life Science, CHA University, CHA Biocomplex, Sampyeong-Dong, Bundang-gu, Seongnam-si, 13488, Republic of Korea
5 shared publicationsGyuwon So
Laboratory of Nano-regenerative Medicine, Department of Biomedical Science, College of Life Science, CHA University, CHA Biocomplex, Sampyeong-Dong, Bundang-gu, Seongnam-si, 13488, Republic of Korea
4 shared publicationsChae Won Cho
Laboratory of Nano-regenerative Medicine, Department of Biomedical Science, College of Life Science, CHA University, CHA Biocomplex, Sampyeong-Dong, Bundang-gu, Seongnam-si, 13488, Republic of Korea
3 shared publicationsHye‐Ryoung Kim
School of Bioconvergence CHA University 6F, CHA Biocomplex, Sampyeong‐Dong, Bundang‐gu Seongnam‐si 13488 Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 7 May 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24
Tumor-targeted liposomal RNAi therapy suppresses breast cancer and modulates tumor microenvironment
Liposomes are widely used nanocarriers, but their clinical translation remains limited by poor tumor selectivity and inefficient nucleic acid delivery. To address these challenges, we designed multifunctional liposomes incorporating phenylboronic acid (PBA) for tumor targeting, ginsenoside Rh2 (Rh2) as both a cholesterol-mimetic stabilizer and intrinsic anticancer agent, and small interfering RNA against vascular endothelial growth factor (VEGF). VEGF was selected for its pivotal role in tumor angiogenesis and to counteract the paradoxical pro-angiogenic effect of Rh2. PBA-modified liposomes exhibited enhanced tumor accumulation and cellular uptake compared with non-targeted controls. Rh2 induced direct cytotoxicity, while VEGF silencing further suppressed angiogenesis together producing synergistic antitumor activity. In vivo, Rh2-PBA-siVEGF liposomes (RhPLIPO-siVEGF) and Rh2-PBA-Negative Control siRNA (siNC) liposomes (RhPLIPO-siNC) were evaluated in a 4T1 orthotopic breast tumor model. Both formulations elicited effects characterized by increased infiltration of T cells and M1 macrophages. Notably, RhPLIPO-siVEGF treatment significantly reduced tumor growth and microvascular density compared with RhPLIPO-siNC, confirming synergy between Rh2-mediated cytotoxicity and VEGF knockdown. Overall, this multifunctional liposomal system integrates tumor targeting, intrinsic cytotoxicity, and RNA interference-mediated anti-angiogenesis with minimal adverse effects, offering a potent and versatile nanoplatform for targeted breast cancer therapy.
- 7 May 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24
Open AccessTumor-targeted liposomal RNAi therapy suppresses breast cancer and modulates tumor microenvironment
Liposomes are widely used nanocarriers, but their clinical translation remains limited by poor tumor selectivity and inefficient nucleic acid delivery. To address these challenges, we designed multifunctional liposomes incorporating phenylboronic acid (PBA) for tumor targeting, ginsenoside Rh2 (Rh2) as both a cholesterol-mimetic stabilizer and intrinsic anticancer agent, and small interfering RNA against vascular endothelial growth factor (VEGF). VEGF was selected for its pivotal role in tumor angiogenesis and to counteract the paradoxical pro-angiogenic effect of Rh2. PBA-modified liposomes exhibited enhanced tumor accumulation and cellular uptake compared with non-targeted controls. Rh2 induced direct cytotoxicity, while VEGF silencing further suppressed angiogenesis together producing synergistic antitumor activity. In vivo, Rh2-PBA-siVEGF liposomes (RhPLIPO-siVEGF) and Rh2-PBA-Negative Control siRNA (siNC) liposomes (RhPLIPO-siNC) were evaluated in a 4T1 orthotopic breast tumor model. Both formulations elicited effects characterized by increased infiltration of T cells and M1 macrophages. Notably, RhPLIPO-siVEGF treatment significantly reduced tumor growth and microvascular density compared with RhPLIPO-siNC, confirming synergy between Rh2-mediated cytotoxicity and VEGF knockdown. Overall, this multifunctional liposomal system integrates tumor targeting, intrinsic cytotoxicity, and RNA interference-mediated anti-angiogenesis with minimal adverse effects, offering a potent and versatile nanoplatform for targeted breast cancer therapy.
- Open Access
- 20 March 2026
- Published by Elsevier in Biomaterials
- Vol. 331, 124146
Orally delivered, pH-resistant dual coated extracellular vesicles restore intestinal barrier function and suppress colitis
- 20 March 2026
- Published by Elsevier in Biomaterials
- Vol. 331, 124146
Open AccessOrally delivered, pH-resistant dual coated extracellular vesicles restore intestinal barrier function and suppress colitis
- Open Access
- 31 January 2025
- Published by Wiley in Advanced Science
- Vol. 12 (12) , e2415303
Near Infrared‐Mediated Intracellular NADH Delivery Strengthens Mitochondrial Function and Stability in Muscle Dysfunction Model
Mitochondrial transfer emerges as a promising therapy for the restoration of mitochondrial function in damaged cells, mainly due to its limited immunogenicity. However, isolated mitochondria rapidly lose function because they produce little energy outside cells. Therefore, this study investigates whether near infrared (NIR)‐mediated nicotinamide adenine dinucleotide (NADH) pre‐treatment enhances mitochondrial function and stability in mitochondria‐donor cells prior to transplantation. Clinical applications of NADH, an essential electron donor in the oxidative phosphorylation process, are restricted due to the limited cellular uptake of NADH. To address this, a photo‐mediated method optimizes direct NADH delivery into cells and increases NADH absorption. L6 cells treated with NADH and irradiated with NIR enhanced NADH uptake, significantly improving mitochondrial energy production and function. Importantly, the improved functional characteristics of the mitochondria are maintained even after isolation from cells. Primed mitochondria, i.e., those enhanced by NIR‐mediated NADH uptake (P‐MT), are encapsulated in fusogenic liposomes and delivered into muscle cells with mitochondrial dysfunction. Compared to conventional mitochondria, P‐MT mitochondria promote greater mitochondrial recovery and muscle regeneration. These findings suggest that NIR‐mediated NADH delivery is an effective strategy for improving mitochondrial function, and has the potential to lead to novel treatments for mitochondrial disorders and muscle degeneration.
- 31 January 2025
- Published by Wiley in Advanced Science
- Vol. 12 (12) , e2415303
Open AccessNear Infrared‐Mediated Intracellular NADH Delivery Strengthens Mitochondrial Function and Stability in Muscle Dysfunction Model
Mitochondrial transfer emerges as a promising therapy for the restoration of mitochondrial function in damaged cells, mainly due to its limited immunogenicity. However, isolated mitochondria rapidly lose function because they produce little energy outside cells. Therefore, this study investigates whether near infrared (NIR)‐mediated nicotinamide adenine dinucleotide (NADH) pre‐treatment enhances mitochondrial function and stability in mitochondria‐donor cells prior to transplantation. Clinical applications of NADH, an essential electron donor in the oxidative phosphorylation process, are restricted due to the limited cellular uptake of NADH. To address this, a photo‐mediated method optimizes direct NADH delivery into cells and increases NADH absorption. L6 cells treated with NADH and irradiated with NIR enhanced NADH uptake, significantly improving mitochondrial energy production and function. Importantly, the improved functional characteristics of the mitochondria are maintained even after isolation from cells. Primed mitochondria, i.e., those enhanced by NIR‐mediated NADH uptake (P‐MT), are encapsulated in fusogenic liposomes and delivered into muscle cells with mitochondrial dysfunction. Compared to conventional mitochondria, P‐MT mitochondria promote greater mitochondrial recovery and muscle regeneration. These findings suggest that NIR‐mediated NADH delivery is an effective strategy for improving mitochondrial function, and has the potential to lead to novel treatments for mitochondrial disorders and muscle degeneration.
- Open Access
- 31 January 2025
- Published by Wiley in Advanced Science
- Vol. 12 (12) , e2412621
Osteoblast‐Derived Mitochondria Formulated with Cationic Liposome Guide Mesenchymal Stem Cells into Osteogenic Differentiation
While mitochondria are known to be essential for intracellular energy production and overall function, emerging evidence highlights their role in influencing cell behavior through mitochondrial transfer. This phenomenon provides a potential basis for the development of treatment strategies for tissue damage and degeneration. This study aims to evaluate whether mitochondria isolated from osteoblasts can promote osteogenic differentiation in mesenchymal stem cells (MSCs). Mitochondria from MSCs, which primarily utilize glycolysis, are compared with those from MG63 cells, which depend on oxidative phosphorylation. Mitochondria from both cell types are then encapsulated in cationic liposomes and transferred to MSCs, and their impact on differentiation is assessed. Mitochondria delivery from MG63 cells to MSCs grown in both two‐ and three‐dimensional cultures results in increased expression of osteogenic markers, including Runt‐related transcription factor 2, Osterix, and Osteopontin, and upregulation of genes involved in Bone morphogenetic protein 2 signaling and calcium import. This is accompanied by increased calcium influx and regulated by the Wnt/β‐catenin signaling pathway. Transplantation of spheroids containing MSCs with MG63‐derived mitochondria in bone defect animal models improves bone regeneration. The results suggest that delivery of MG63‐derived mitochondria effectively guides MSCs toward osteogenesis, paving the way for the development of mitochondria‐transplantation therapies.
- 31 January 2025
- Published by Wiley in Advanced Science
- Vol. 12 (12) , e2412621
Open AccessOsteoblast‐Derived Mitochondria Formulated with Cationic Liposome Guide Mesenchymal Stem Cells into Osteogenic Differentiation
While mitochondria are known to be essential for intracellular energy production and overall function, emerging evidence highlights their role in influencing cell behavior through mitochondrial transfer. This phenomenon provides a potential basis for the development of treatment strategies for tissue damage and degeneration. This study aims to evaluate whether mitochondria isolated from osteoblasts can promote osteogenic differentiation in mesenchymal stem cells (MSCs). Mitochondria from MSCs, which primarily utilize glycolysis, are compared with those from MG63 cells, which depend on oxidative phosphorylation. Mitochondria from both cell types are then encapsulated in cationic liposomes and transferred to MSCs, and their impact on differentiation is assessed. Mitochondria delivery from MG63 cells to MSCs grown in both two‐ and three‐dimensional cultures results in increased expression of osteogenic markers, including Runt‐related transcription factor 2, Osterix, and Osteopontin, and upregulation of genes involved in Bone morphogenetic protein 2 signaling and calcium import. This is accompanied by increased calcium influx and regulated by the Wnt/β‐catenin signaling pathway. Transplantation of spheroids containing MSCs with MG63‐derived mitochondria in bone defect animal models improves bone regeneration. The results suggest that delivery of MG63‐derived mitochondria effectively guides MSCs toward osteogenesis, paving the way for the development of mitochondria‐transplantation therapies.
- Open Access
- 15 October 2023
- Published by Elsevier in Biomaterials
- Vol. 302, 122350
Fusogenic liposomes encapsulating mitochondria as a promising delivery system for osteoarthritis therapy
- 15 October 2023
- Published by Elsevier in Biomaterials
- Vol. 302, 122350
Open AccessFusogenic liposomes encapsulating mitochondria as a promising delivery system for osteoarthritis therapy
- Open Access
- 7 December 2018
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 9 (1) , 1-13
Gene expression profiling of chondrogenic differentiation by dexamethasone-conjugated polyethyleneimine with SOX trio genes in stem cells
During differentiation of stem cells, it is recognized that molecular mechanisms of transcription factors manage stem cells towards the intended lineage. In this study, using microarray-based technology, gene expression profiling was examined during the process of chondrogenic differentiation of human mesenchymal stem cells (hMSCs). To induce chondrogenic differentiation of hMSCs, the cationic polymer polyethyleneimine (PEI) was coupled with the synthetic glucocorticoid dexamethasone (DEX). DEX/PEI could be polyplexed with anionic plasmid DNAs (pDNAs) harboring the chondrogenesis-inducing factors SOX5, SOX6, and SOX9. These are named differentiation-inducing nanoparticles (DI-NPs). A DI-NP system for inducing chondrogenic differentiation was designed and characterized by dynamic light scattering and scanning electron microscopy (SEM). Chondrogenic induction of hMSCs was evaluated using various tools such as reverse-transcription polymerase chain reaction (RT-PCR), Western blotting, confocal fluorescent microscopy, and immunohistochemistry analysis. The gene expression profiling of DI-NP-treated hMSCs was performed by microarray analysis. The hMSCs were more efficiently transfected with pDNAs using DI-NPs than using PEI. Moreover, microarray analysis demonstrated the gene expression profiling of hMSCs transfected with DI-NPs. Chondrogenic factors including SOX9, collagen type II (COLII), Aggrecan, and cartilage oligometric matrix protein (COMP) were upregulated while osteogenic factors including collagen type I (COLI) was downregulated. Chondrogenesis-induced hMSCs were better differentiated as assessed by RT-PCR, Western blotting analyses, and immunohistochemistry. DI-NPs are good gene delivery carriers and induce chondrogenic differentiation of hMSCs. Additionally, comprehensive examination of the gene expression was attempted to identify specific genes related to differentiation by microarray analysis.
- 7 December 2018
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 9 (1) , 1-13
Open AccessGene expression profiling of chondrogenic differentiation by dexamethasone-conjugated polyethyleneimine with SOX trio genes in stem cells
During differentiation of stem cells, it is recognized that molecular mechanisms of transcription factors manage stem cells towards the intended lineage. In this study, using microarray-based technology, gene expression profiling was examined during the process of chondrogenic differentiation of human mesenchymal stem cells (hMSCs). To induce chondrogenic differentiation of hMSCs, the cationic polymer polyethyleneimine (PEI) was coupled with the synthetic glucocorticoid dexamethasone (DEX). DEX/PEI could be polyplexed with anionic plasmid DNAs (pDNAs) harboring the chondrogenesis-inducing factors SOX5, SOX6, and SOX9. These are named differentiation-inducing nanoparticles (DI-NPs). A DI-NP system for inducing chondrogenic differentiation was designed and characterized by dynamic light scattering and scanning electron microscopy (SEM). Chondrogenic induction of hMSCs was evaluated using various tools such as reverse-transcription polymerase chain reaction (RT-PCR), Western blotting, confocal fluorescent microscopy, and immunohistochemistry analysis. The gene expression profiling of DI-NP-treated hMSCs was performed by microarray analysis. The hMSCs were more efficiently transfected with pDNAs using DI-NPs than using PEI. Moreover, microarray analysis demonstrated the gene expression profiling of hMSCs transfected with DI-NPs. Chondrogenic factors including SOX9, collagen type II (COLII), Aggrecan, and cartilage oligometric matrix protein (COMP) were upregulated while osteogenic factors including collagen type I (COLI) was downregulated. Chondrogenesis-induced hMSCs were better differentiated as assessed by RT-PCR, Western blotting analyses, and immunohistochemistry. DI-NPs are good gene delivery carriers and induce chondrogenic differentiation of hMSCs. Additionally, comprehensive examination of the gene expression was attempted to identify specific genes related to differentiation by microarray analysis.